THE Therapeutic Goods Administration has revised one of its alerts relating to counterfeit drugs (PD yesterday), to reflect that its concerns were specifically related to a product named Euro Med Clomid tablets.
The new version highlights the fact that 'Euro Med Clomid tablets' are not related to the TGA-approved Sanofi-Aventis Clomid (50mg Clomiphine Citrate) available in a blister pack presentation.
The Sanofi product continues to be marketed in Australia as an approved alternative to address current medicine shortages of clomifene/clomiphene 50mg tablets.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Nov 17
